Security key
007002108
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)
CUSIP: 007002108
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, par value $0.0001
- Total 13F shares
- 33,363,531
- Total 13F value
- $63,033,300
- Share change
- -2,113,650
- Put/Call ratio
- 1024%
- SEC-reported price per share
- $1.89
- Number of holders
- 76
- Value change
- -$3,182,870
- Number of buys
- 34
- Number of sells
- 39
- Shares outstanding
- 9,599,852
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
76
Top holders
10
ACET full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Adicet Bio, Inc. SEC filings
Adicet Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 007002108
Recent filing periods:
Ownership snapshot
Top reported holders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 87%
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 87%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
87%
RTW INVESTMENTS, LP
44%
MORGAN STANLEY
40%
COWEN AND COMPANY, LLC
28%
BlackRock Finance, Inc.
24%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
87%
|
$11,401,332
8,322,140 shares
|
— | 30 Sep 2023 |
| RTW INVESTMENTS, LP |
13F
Company
|
44%
|
$5,810,817
4,241,472 shares
|
— | 30 Sep 2023 |
| MORGAN STANLEY |
13F
Company
|
40%
|
$5,255,836
3,836,377 shares
|
— | 30 Sep 2023 |
| COWEN AND COMPANY, LLC |
13F
Company
|
28%
|
$3,719,930
2,715,278 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
24%
|
$3,109,184
2,269,478 shares
|
— | 30 Sep 2023 |
| Carlyle Group Inc. |
13F
Company
|
22%
|
$2,876,924
2,115,385 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
76
Shares
33,363,531
Rows available
76
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
83
Q4 2023 holders
76
Holder diff
-7
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend